Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
| 18 | 3 | HEMATOLOGY//THROMBOSIS AND HAEMOSTASIS//THROMBOSIS RESEARCH | 124610 |
| 518 | 2 | ASPIRIN RESISTANCE//ASPIRIN//THROMBOSIS RESEARCH | 15555 |
| 27776 | 1 | 4 5 DIARRYLPYRROLES//ANTIINFLAMMATORY LIPOXYGENASE INHIBITOR//ATELOCOLLAGEN AC | 241 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | 4 5 DIARRYLPYRROLES | authKW | 130775 | 0% | 100% | 1 |
| 2 | ANTIINFLAMMATORY LIPOXYGENASE INHIBITOR | authKW | 130775 | 0% | 100% | 1 |
| 3 | ATELOCOLLAGEN AC | authKW | 130775 | 0% | 100% | 1 |
| 4 | BENZOIC AND SALICYLIC ACIDS | authKW | 130775 | 0% | 100% | 1 |
| 5 | BIOREGULATORS | address | 130775 | 0% | 100% | 1 |
| 6 | CNRSUA 481 | address | 130775 | 0% | 100% | 1 |
| 7 | ENERGY OF THE HIGHEST OCCUPIED MOLECULAR ORBITAL LIPOPHILICITY CYCLOOXYGENASE 2 AND 1 INHIBITIONS | authKW | 130775 | 0% | 100% | 1 |
| 8 | HOMO SURFACE | authKW | 130775 | 0% | 100% | 1 |
| 9 | INDUCTION OF ENZYME SYNTHESIS | authKW | 130775 | 0% | 100% | 1 |
| 10 | INDUCTION OF PHASE 2 ENZYMES | authKW | 130775 | 0% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 1585 | 47% | 0% | 114 |
| 2 | Hematology | 573 | 15% | 0% | 37 |
| 3 | Peripheral Vascular Diseases | 457 | 13% | 0% | 32 |
| 4 | Endocrinology & Metabolism | 154 | 11% | 0% | 26 |
| 5 | Toxicology | 69 | 6% | 0% | 14 |
| 6 | Medicine, General & Internal | 33 | 7% | 0% | 17 |
| 7 | Chemistry, Medicinal | 32 | 4% | 0% | 10 |
| 8 | Cardiac & Cardiovascular System | 16 | 5% | 0% | 11 |
| 9 | Chemistry, Multidisciplinary | 8 | 7% | 0% | 17 |
| 10 | Biochemistry & Molecular Biology | 6 | 9% | 0% | 22 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | BIOREGULATORS | 130775 | 0% | 100% | 1 |
| 2 | CNRSUA 481 | 130775 | 0% | 100% | 1 |
| 3 | KOREAN NUTRIT SCI | 130775 | 0% | 100% | 1 |
| 4 | KOKEN | 43590 | 0% | 33% | 1 |
| 5 | BIOPHYS PHOTOBIOL | 26153 | 0% | 20% | 1 |
| 6 | CNRS ESA 8041 | 21794 | 0% | 17% | 1 |
| 7 | UA 351 | 21794 | 0% | 17% | 1 |
| 8 | UMR CNRS MNHN 7245 | 8172 | 0% | 6% | 1 |
| 9 | MED MED CLIN PHARMACOL | 5684 | 0% | 4% | 1 |
| 10 | INSERMU201 | 5447 | 0% | 4% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | PROSTAGLANDINS LEUKOTRIENES AND MEDICINE | 33598 | 6% | 2% | 15 |
| 2 | PROSTAGLANDINS AND MEDICINE | 9210 | 2% | 2% | 4 |
| 3 | THROMBOSIS RESEARCH | 7278 | 10% | 0% | 24 |
| 4 | ACTA PHARMACOLOGICA ET TOXICOLOGICA | 4140 | 2% | 1% | 6 |
| 5 | HAEMOSTASIS | 3800 | 2% | 0% | 6 |
| 6 | AGENTS AND ACTIONS | 1987 | 3% | 0% | 7 |
| 7 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1469 | 4% | 0% | 9 |
| 8 | FARMACO-EDIZIONE SCIENTIFICA | 1412 | 1% | 0% | 3 |
| 9 | CURRENT CONTENTS/CLINICAL PRACTICE | 1028 | 0% | 1% | 1 |
| 10 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | 614 | 1% | 0% | 3 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |